Form 4: Director Heilbronn Exercises IPAR Stock Options
Insider Transaction Report
Interparfums Inc. Director and 10% owner Francois Heilbronn exercised options to acquire 1,500 shares of common stock at $62.18 per share, increasing his direct beneficial ownership to 30,063 shares.
Summary
- Director and 10% owner Francois Heilbronn acquired 1,500 shares of Interparfums Inc. common stock.
- The acquisition occurred on January 23, 2026, through the exercise of derivative securities (options).
- The exercise price for these shares was $62.18 per share.
- Following this transaction, Heilbronn directly beneficially owns 30,063 shares of common stock.
- Heilbronn continues to hold various other stock options with exercise prices ranging from $84.64 to $147.71, expiring between 2028 and 2031.
Sentiment
Score: 6
Explanation: The exercise of options by a director and 10% owner to increase direct shareholding is generally a positive signal, indicating confidence in the company's future. However, it's a routine insider transaction and doesn't reflect significant new operational or financial news.
Positives
- An insider (Director and 10% owner) increased their direct ownership in the company, which can signal confidence in future performance.
- The exercise price of $62.18 is below the current market price (implied, as options are typically exercised when in-the-money), indicating a profitable transaction for the insider.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This insider transaction is a routine disclosure and does not provide specific insights into broader industry trends or competitive landscape for Interparfums Inc. However, insider buying (or option exercise leading to ownership) can sometimes be interpreted as a positive signal regarding the company's prospects within its industry.
Comparison to Industry Standards
- This filing is a standard insider transaction disclosure and does not contain information that allows for a direct comparison to industry-specific benchmarks or competitor results. The exercise of options at a specific price is a personal financial decision of the insider, not a company performance metric.
Stakeholder Impact
- Shareholders: Increased insider ownership may be viewed positively, signaling management's belief in the company's value.
- Employees, Customers, Suppliers, Creditors: No direct impact from this specific insider transaction.
Next Steps
- The remaining unexercised options held by Francois Heilbronn will become exercisable on various dates between 2023 and 2030, with expiration dates between 2028 and 2031.
Key Dates
| Date | Description |
|---|---|
| 02/01/2022 | Earliest exercisable date for a tranche of options exercised on 01/23/2026. |
| 02/01/2023 | Earliest exercisable date for a tranche of options exercised on 01/23/2026. |
| 12/31/2023 | Earliest exercisable date for a tranche of options with an exercise price of $97.84. |
| 02/01/2024 | Earliest exercisable date for a tranche of options exercised on 01/23/2026. |
| 12/29/2024 | Earliest exercisable date for a tranche of options with an exercise price of $147.71. |
| 12/31/2024 | Earliest exercisable date for a tranche of options with an exercise price of $97.84. |
| 02/01/2025 | Earliest exercisable date for a tranche of options exercised on 01/23/2026. |
| 12/29/2025 | Earliest exercisable date for a tranche of options with an exercise price of $147.71. |
| 12/31/2025 | Earliest exercisable date for a tranche of options with an exercise price of $97.84 and $130.60. |
| 01/23/2026 | Date of option exercise transaction. |
| 01/26/2026 | Date the Form 4 was signed and filed. |
| 01/31/2026 | Expiration date for options exercised on 01/23/2026. |
| 12/29/2026 | Earliest exercisable date for a tranche of options with an exercise price of $147.71. |
| 12/31/2026 | Earliest exercisable date for a tranche of options with an exercise price of $97.84, $130.60, and $84.64. |
| 12/29/2027 | Earliest exercisable date for a tranche of options with an exercise price of $147.71. |
| 12/31/2027 | Earliest exercisable date for a tranche of options with an exercise price of $97.84, $130.60, and $84.64. |
| 12/28/2028 | Expiration date for options with an exercise price of $147.71. |
| 12/29/2028 | Earliest exercisable date for a tranche of options with an exercise price of $147.71. |
| 12/30/2028 | Expiration date for options with an exercise price of $97.84. |
| 12/31/2028 | Earliest exercisable date for a tranche of options with an exercise price of $97.84, $130.60, and $84.64. |
| 12/28/2029 | Expiration date for options with an exercise price of $147.71. |
| 12/31/2029 | Earliest exercisable date for a tranche of options with an exercise price of $130.60 and $84.64. |
| 12/30/2030 | Expiration date for options with an exercise price of $130.60. |
| 12/31/2030 | Earliest exercisable date for a tranche of options with an exercise price of $84.64. |
| 12/30/2031 | Expiration date for options with an exercise price of $84.64. |
Recommendation
holdThis Form 4 filing reports a routine insider transaction where a director and 10% owner exercised stock options. While an increase in insider ownership can be a positive signal of confidence, this specific transaction does not provide new fundamental information about Interparfums Inc.'s operational performance, financial health, or strategic direction that would warrant a change from a 'hold' position. Investors should consider broader company fundamentals and market conditions rather than solely relying on this single insider transaction.
Keywords
Interparfums Inc., IPAR, Francois Heilbronn, Insider Trading, Stock Options, Beneficial Ownership, Director, 10% Owner, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.